Deep Vein Thrombosis Market Growth Trajectory – Insights On Key Drivers, Major Trends, And Top Opportunities
24 Jul, 2023
The global deep vein thrombosis market size is expected to grow from $0.98 billion in 2022 to $1.03 billion in 2023 at a compound annual growth rate (CAGR) of 4.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global deep vein thrombosis market size is expected to reach $1.20 billion in 2027 at a CAGR of 4%.
Global Deep Vein Thrombosis Market Key Driver
The growing number of people who need deep vein thrombosis (DVT) therapy is predicted to drive the deep vein thrombosis market forward. DVT treatment refers to the use of pharmaceuticals such as anticoagulants and others to prevent the creation of new blood clots and the growth of existing blood clots, hence easing the medical condition. The rise in the number of patients requiring DVT treatment shows an increase in the prevalence of DVT, necessitating items for DVT diagnosis, prophylaxis, and treatment.
Get a sample of the global deep vein thrombosis market reportGlobal Deep Vein Thrombosis Market Segments
The global deep vein thrombosis market is segmented:
1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class
2) By Treatment: Surgery, Drugs, Other Treatments
3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users
6) By Geography: The regions covered in the deep vein thrombosis market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global deep vein thrombosis market.
Major Deep Vein Thrombosis Industry Players
Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis, Daiichi Sankyo Company, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Momenta Pharmaceutical Inc., Hikma Pharmaceuticals PLC, Laboratorios Farmaceuticos Rovi SA, Cardinal Health, Altimed Ltd.
Get the full global deep vein thrombosis market report
Deep Vein Thrombosis Market Overview
Deep vein thrombosis (DVT) refers to a serious medical condition that occurs when a blood clot forms in one or more of the deep veins in the body. The symptoms of DVT can include swelling, pain, and tenderness in the affected area, usually the leg.
Deep Vein Thrombosis Global Market Report 2023 provides data on the global deep vein thrombosis market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The deep vein thrombosis market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.